Navigation Links
MULTAQ(R) (dronedarone) for Atrial Fibrillation or Atrial Flutter Now Available in the United States
Date:7/28/2009

AQ had higher rates of diarrhea, nausea, bradycardia, QT-interval prolongation and cutaneous rash than patients taking placebo.

Initiation of MULTAQ treatment is contraindicated in patients with severe heart failure (NYHA class IV) or NYHA Class II - III heart failure with a recent decompensation requiring hospitalization or referral to a specialized heart failure clinic. This unstable population corresponds to the population of the ANDROMEDA trial in which patients receiving dronedarone had a greater than two-fold increase in mortality compared to placebo.

To ensure the use of MULTAQ in the appropriate patient population, sanofi-aventis U.S. LLC also announced the launch of mPACT MULTAQ((R)) Partnership for Appropriate Care and Treatment(TM), the Risk Evaluation and Mitigation Strategy (REMS). The mPACT Partnership was developed to assist healthcare professionals (HCPs) with the identification of appropriate patients and to ensure the safe use of MULTAQ while minimizing risk. The risk mitigation program consists of a Communication Plan for HCPs, a medication guide for patients and post-marketing surveillance.

There are approximately 2.5 million Americans with AF and the incidence is growing worldwide in relation to the aging population. Atrial fibrillation is a complex disease that increases the risk of stroke up to five-fold, worsens the prognosis of patients with cardiovascular risk factors, and doubles the risk of mortality.

About MULTAQ(R) (dronedarone)

MULTAQ, discovered and developed by sanofi-aventis, has been studied in a clinical development program involving nearly 6,300 patients including more than 3,200 patients who received MULTAQ. It represents one of the few new treatment options for AF/AFL patients in the last 10 years. MULTAQ is to be given twice daily as a 400 mg tablet and should be taken as one tablet with the morning and evening meals. Treat
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
2. CardioFocus Receives CE Mark for Atrial Fibrillation Ablation Catheter
3. Atrial fibrillation linked to increased hospitalization in heart failure patients
4. Redesigned Corporate Identity and nowEDC Software Upgrade Reflect Datatrials Commitment To Stress Free Study Delivery
5. Atrial fibrillation in endurance athletes still poses problems for sports cardiologists
6. Frost & Sullivan: Momentum Mounting for Catheter Ablation Technologies in Treatment of Atrial Fibrillation
7. Health and Advocacy Leaders Mobilize to Bring Attention to Atrial Fibrillation, a Costly and Misunderstood Cardiovascular Disease
8. eCardio Launches NEW Atrial Fibrillation Information System (AFIS(TM))
9. Catheter Ablation Effective in Treating Atrial Fibrillation
10. For Atrial Fibrillation, Surveyed Experts Indicate That Multaq, Celivarone and ATI-2042 Have Advantages Over Propafenone in the Maintenance of Normal Sinus Rhythm
11. Larger Men at Greater Risk for Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Project Veritas is releasing a video ... MIT economist and Obamacare architect Jonathan Gruber to public ... the interview, which is being distributed on YouTube. , ... mislabeling in the Affordable Care Act in order to ... billion dollar per year tax grab. , “President Obama ...
(Date:12/17/2014)... -- Greater participation in music classes may benefit children,s ... kids in the nonprofit Harmony Project, which provides music ... Over two years, children who actively participated in ... processes speech and reading, compared to those with lower ... participation in music classes occurred in the same areas ...
(Date:12/15/2014)... Cancer researchers have just published an important new report ... pleural mesothelioma. Surviving Mesothelioma has just posted an article ... to read it now. , Doctors at Harvard, ... York’s Langone Medical Center performed complete genetic analyses on ... effort to pinpoint the genes that are most likely ...
(Date:12/15/2014)... 15, 2014 OutMarket , a ... “ Social Media Cheat Sheets ,” a guide that ... drives results on the top ten social media networks. ... helps drive awareness, engagement, and customer service. It can ... make an impact on new networks and weather constantly ...
(Date:12/15/2014)... Kathy McAfee, America's Marketing Motivator, was ... in the category of Best Blog 2014. McAfee received ... weekly career blog Networking Ahead which combines ... elevate their talent and influence through better networking, leadership ... book Networking Ahead for Business, has been motivating readers ...
Breaking Medicine News(10 mins):Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:Music Classes Boost Language Skills, Study Says 2Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News:Kathy McAfee, America’s Marketing Motivator, Wins Best Blog from Women World Awards 2
... a new business to battle the rising costs of making funeral arrangements ... in these difficult economic times, for families to try to cut costs ... ... -- Grief Counseling Services (GCS), located in New York, recently announced the ...
... launch of new professional massage therapy marketing tool and search directory ... ... Atlanta, GA (PRWEB) February 18, 2009 -- This new membership based ... therapists in their city and post their profiles to promote their ...
... With sexual activity among adolescents in the United ... and reports of up to 25 percent of all ... researchers and public health officials are looking for those ... an article published in the April 2009 issue of ...
... provide trauma relief ,to both sides of the conflict ... team plans a training of health and mental health ... its kind working in both Israel and Gaza. ... for Mind-Body Medicine,s groundbreaking model which teaches self-care techniques ...
... Feb. 23 Campaign for America,s Future co-director ... Mishel and Center for Economic and Policy Research ... statement after participating in President Obama ,s summit ... ROGER HICKEY, DEAN BAKER AND LAWRENCE ...
... non-profit LENA(TM) Foundation, which develops technology for the improved ... two case studies showing how the breakthrough LENA system ... LENA software enables the clinician to measure adult word ... hourly intervals over the course of an entire day. ...
Cached Medicine News:Health News:Grief Counseling Services Battles Rising Costs of Funeral Expenses 2Health News:Grief Counseling Services Battles Rising Costs of Funeral Expenses 3Health News:MassageLinkUp.com Announces New Massage Directory for Professional Massage Therapists 2Health News:Sexual lyrics in popular songs linked to early sexual experiences 2Health News:Paving the Way for Peace in the Middle East with Mind-Body Skills 2Health News:Paving the Way for Peace in the Middle East with Mind-Body Skills 3Health News:Paving the Way for Peace in the Middle East with Mind-Body Skills 4Health News:Progressive Leaders at White House Summit Today Underscore Need for Health Care Reform 2Health News:LENA Foundation Technology Measures Effectiveness of Autism Therapy 2Health News:LENA Foundation Technology Measures Effectiveness of Autism Therapy 3
(Date:12/17/2014)... Ariz. , Dec. 17, 2014  Beamz ... state-of-the-art interactive music products, today announced that it ... a leading manufacturer and supplier of innovative prosthetic, ... As part of the agreement, RSL Steeper ... bundled solution specifically configured for use within UK ...
(Date:12/17/2014)... and RALEIGH, N.C. , Dec. ... LLC (CTMC), and Integrated Clinical Trial Services, LLC ... retention for clinical trials announce that they have ... Marketing Services (i-CTMS). i-CTMS will provide a broad ... pharmaceutical, biotechnology and medical device companies. ...
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/32cmct/inferior_vena ) ... Cava (IVC) Filters - Global Trends, Estimates and Forecasts, ... http://photos.prnewswire.com/prnh/20130307/600769 Global Inferior Vena ... million by 2016. The North America ... value while Europe claims approximately ...
Breaking Medicine Technology:Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 4
... Genomic Health, Inc. (Nasdaq: GHDX ) today ... to study early-stage renal cell carcinoma prognosis, which demonstrated a ... patient population.  The study, which will be presented in an ... at the ASCO annual meeting in Chicago , could ...
... China , June 4 /PRNewswire-Asia-FirstCall/ -- Jiangbo,Pharmaceuticals, Inc. (OTC Bulletin ... in China , today,announced that the Company has received approval to ... , , ... common stock will begin trading on the NASDAQ,Global Market on Tuesday, ...
Cached Medicine Technology:Genomic Health Announces Results From the Largest Genomic Analysis of Localized Clear Cell Renal Carcinoma at American Society of Clinical Oncology (ASCO) Annual Meeting 2Genomic Health Announces Results From the Largest Genomic Analysis of Localized Clear Cell Renal Carcinoma at American Society of Clinical Oncology (ASCO) Annual Meeting 3Genomic Health Announces Results From the Largest Genomic Analysis of Localized Clear Cell Renal Carcinoma at American Society of Clinical Oncology (ASCO) Annual Meeting 4Genomic Health Announces Results From the Largest Genomic Analysis of Localized Clear Cell Renal Carcinoma at American Society of Clinical Oncology (ASCO) Annual Meeting 5Jiangbo Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Global Market 2Jiangbo Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Global Market 3
... you to scan every beating heart at any ... possible. A scanner using two X-ray sources ... provides one-stop diagnosis in acute care; even with ... Combined with the Cardiac Engine, a unique combination ...
... can code the charge while completing a chart ... away from office, both directly feeding the charge ... Encounter Form/Superbill, data entry can be done with ... payments are posted by reflecting open item charges, ...
... lens incorporate 3 mirrors angled at 76°, 66° ... anterior chamber as well as central and peripheral ... mirrors are accurately angled and spaced 120° apart ... The central portion of the lens also provides ...
The Mid Field 30° lens has a bi-concave design to provide a wider field of view with a 30 degree offset image....
Medicine Products: